The Digipharmax 2016 — the Digital Pharma Excellence Awards, held on 24 June at ITC Grand Central, Mumbai, was organised by BW Businessworld to recognise and felicitate leaders in digital in the pharma industry.
The awards included 15 categories in the digital space. “We are in a business of building communities and we have recorded almost 10 million page views. I hope this initiative will grow and become a marquee one in this domain in the coming years. In the coming few weeks, we are also planning to have an increased engagement with the pharma sector,” said Anurag Batra, chairman and editor-in-chief of BWBusinessworld.
According to industry leaders who participated in the high-powered panel discussions, digitisation not only enhances the performance of organisations but also brings the much-needed transparency in the industry. The pharmaceutical and healthcare sectors, which are moving fast towards a digital culture, will be able to make much better impacts in the treatment outcome.
Cipla, Wockhardt, Abbott, GlaxoSmithKline, Pfizer and Johnson & Johnson were among the winners of DigiPharmaX 2016 awards.
Janssen Pharma — a division of Johnson & Johnson — which won the ‘Digital Pioneer Award’, has shown that pharma companies can take the lead in using the digital medium. Janssen also won two awards for its migraine consumer awareness digital campaign titled ‘Me Without Migraine’. Many patients don’t realise they have migraine, confuse it with headache and continue taking painkillers. For the first time, a campaign in migraine space was launched across digital and non-digital channels. The digital solution includes Website, Facebook page, twitter account and launch video. The non-digital route includes in-clinic promotional activities, POP activation and corporate outreach programmes. Within a year of launch, the campaign has a Facebook page of 40,000-plus followers, with almost 22,000 people visiting the website every month. And it’s growing.
